[Prostate cancer and disseminated intravascular coagulation: review of the literature].
Disseminated intravascular coagulation is a rare complication of prostatic cancer evolution. Occurring on hormonorefractory phase, it remains most often infraclinic. Cases of acute, severe intravascular disseminated coagulation at first presentation are life-threatening because of hemorragic and thrombotic complications, justifying emergency medical treatment. In the light of a review of literature, we insist on epidemiological features, physiopathology and therapeutics of intravascular disseminated coagulation. In spite of a pejorative prognosis, this could help to achieve a period of remission.
Chargari
C
C
Service d'oncologie radiothérapie, hôpital d'instruction des armées du Val-de-Grâce, 74, boulevard de Port-Royal, 75230 Paris, France. chargari-vdg@hotmail.fr <chargari-vdg@hotmail.fr>
Vedrine
L
L
Bauduceau
O
O
Le Moulec
S
S
Fayolle
M
M
Ceccaldi
B
B
Houlgatte
A
A
D000925:Anticoagulants / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001706:Biopsy; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology* / Q000473:pathology; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D008297:Male; D011467:Prostate / Q000473:pathology; D011471:Prostatic Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D013927:Thrombosis / Q000209:etiology
D000925:Anticoagulants; D000970:Antineoplastic Agents